🇺🇸 Solifenacin plus Tamsulosin in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Dizziness — 1 report (50%)
- Fall — 1 report (50%)
Other Urology approved in United States
Frequently asked questions
Is Solifenacin plus Tamsulosin approved in United States?
Solifenacin plus Tamsulosin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Solifenacin plus Tamsulosin in United States?
Soonchunhyang University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.